$LNTH News

Mizuho Maintains Outperform on Lantheus Holdings, Lowers Price Target to $115

LNTH Stock Drops After-Hours As Curium's $7B Offer Comes In Below Market Value

Lantheus to Host Second Quarter 2026 Earnings Conference Call and Webcast on August 6, 2026, at 8:00 a.m. Eastern Time

Lantheus Holdings (NASDAQ:LNTH) Is a High-Quality Technical Breakout Setup

Truist Securities Maintains Buy on Lantheus Holdings, Raises Price Target to $125

Mizuho Maintains Market Outperform on Lantheus Holdings, Raises Price Target to $120

3 Reasons to Avoid LNTH and 1 Stock to Buy Instead

B. Riley Securities Maintains Buy on Lantheus Holdings, Raises Price Target to $129

FDA Manufacturing Issues Delay Lantheus' Tumor Imaging Kit

Citizens Reiterates Market Outperform on Lantheus Holdings, Maintains $115 Price Target

Lantheus Receives Complete Response Letter from FDA for LNTH-2501 (Ga 68 edotreotide)

Lantheus Holdings Receives FDA Complete Response Letter For LNTH-2501 Due To Manufacturing Facility Issues; No Safety Or Efficacy Concerns Identified

Healthcare Equipment and Supplies Stocks Q1 Teardown: Lantheus (NASDAQ:LNTH) Vs The Rest

Lantheus: The Turnaround Is Working, But The Easy Money Has Been Made

Lantheus Holdings, Inc. (LNTH) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

Assessing Lantheus Holdings (LNTH) Valuation After Strong Multi Month Share Price Gains

Lantheus to Present at the Goldman Sachs 47th Annual Global Healthcare Conference

Lantheus' LNTH-2513 (18F-GP1) PET/CT Awarded SNMMI’s Image of the Year

Lantheus to Present at the William Blair 46th Annual Growth Stock Conference

Mizuho Maintains Outperform on Lantheus Holdings, Raises Price Target to $115